Abstract
Glial cell line-derived neurotrophic factor (GDNF) promotes development and differentiation of dopaminergic neurons, thus it has an important role in dopamine-related neuropsychiatric disorders. Since the role of dopamine system in smoking is well established, we hypothesized that GDNF gene variants may affect smoking behaviour. Self-reported data on smoking behaviour (never smoked, quit, occasional, or regular smokers) and level of nicotine addiction (Hooked on Nicotine Checklist and Fagerstrom Nicotine Addiction Scale), anxiety, as well as buccal samples were obtained from 930 Hungarian young adults (18–35 years). Genetic analysis involved eight GDNF single-nucleotide polymorphisms (SNP) (rs1981844, rs3812047, rs3096140, rs2973041, rs2910702, rs1549250, rs2973050 and rs11111). Allele-wise association analyses of the eight GDNF SNPs provided a significant association between smoking behaviour and rs3096140 (P = 0.0039). The minor allele (C) was more frequent in those groups who smoked in some form (quit, occasional or regular smokers) as compared to those who never smoked (P = 0.0046). This result remained significant after Bonferroni correction for multiple testing. In the ever smoking group, no significant differences were found in the level of nicotine addiction by the alleles of these polymorphisms. Also, no significant interaction of rs3096140 and smoking categories were observed on anxiety mean scores. Although previous data demonstrated an association between GDNF rs2910704 and severity of methamphetamine use to the best of our knowledge, this is the first study on the role of GDNF genetic variations in smoking behaviour. Our results suggest that GDNF rs3096140 might be involved in the genetic background of smoking, independent of anxiety characteristics.
Similar content being viewed by others
References
Airavaara M., Planken A., Gaddnas H., Piepponen T. P., Saarma M. and Ahtee L. 2004 Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. Eur. J. Neurosci. 20, 2336–2344.
Audrain-McGovern J., Rodriguez D. and Kassel J. D. 2009 Adolescent smoking and depression: evidence for self-medication and peer smoking mediation. Addiction 104, 1743–1756.
Balfour D. J. and Ridley D. L. 2000 The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Pharmacol. Biochem. Behav. 66, 79–85.
Berrettini W., Yuan X., Tozzi F., Song K., Francks C., Chilcoat H. et al. 2008 Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol. Psychiatry 13, 368–373.
Bogdanovica I., Godfrey F., McNeill A. and Britton J. 2011 Smoking prevalence in the European Union: a comparison of national and transnational prevalence survey methods and results . Tob. Control 20, e4.
Bonferroni C. E. 1936 Teoria statistica delle classi e calcolo delle probabilità. Pubbl. d. R Ist. Super. di Sci. Economi. e Commerciali di Firenze 8, 3–62.
Covey L. S., Glassman A. H. and Stetner F. 1990 Depression and depressive symptoms in smoking cessation. Compr. Psychiatry 31, 350–354.
Dani J. A. and Heinemann S. 1996 Molecular and cellular aspects of nicotine abuse. Neuron 16, 905–908.
DiFranza J. R., Savageau J. A., Fletcher K., Ockene J. K., Rigotti N. A., McNeill A. D. et al. 2002 Measuring the loss of autonomy over nicotine use in adolescents: the DANDY (Development and Assessment of Nicotine Dependence in Youths) study. Arch. Pediatr. Adolesc. Med. 156, 397–403.
Gill S. S., Patel N. K., Hotton G. R., O’Sullivan K., McCarter R., Bunnage M. et al. 2003 Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589–595.
Granholm A. C., Reyland M., Albeck D., Sanders L., Gerhardt G., Hoernig G. et al. 2000 Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J. Neurosci. 20, 3182–3190.
Griffin W. C. 3., Boger H. A., Granholm A. C. and Middaugh L. D. 2006 Partial deletion of glial cell line-derived neurotrophic factor (GDNF) in mice: Effects on sucrose reward and striatal GDNF concentrations. Brain Res. 1068, 257–260.
Heatherton T. F., Kozlowski L. T., Frecker R. C. and Fagerstrom K. O. 1991 The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 86, 1119–1127.
Hudson J., Granholm A. C., Gerhardt G. A., Henry M. A., Hoffman A., Biddle P. et al. 1995 Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425–432.
Kendler K. S., Neale M. C., MacLean C. J., Heath A. C., Eaves L. J. and Kessler R. C. 1993 Smoking and major depression. A causal analysis. Arch. Gen. Psychiatry 50, 36–43.
Kotyuk E., Keszler G., Nemeth N., Ronai Z., Sasvari-Szekely M. and Szekely A. 2013a Glial Cell Line-Derived Neurotrophic Factor (GDNF) as a Novel Candidate Gene of Anxiety. PLoS One 8, e80613.
Kotyuk E., Nemeth N., Halmai Z., Faludi G., Sasvari-Szekely M. and Szekely A. 2013b Association between mood characteristics and polymorphisms of glial cell line-derived neurotrophic factor (GNDF) in patients with depression. Neuropsychopharmacol. Hung. 15, 63–72.
Lang A. E., Gill S., Patel N. K., Lozano A., Nutt J. G., Penn R. et al. 2006 Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 59, 459–466.
Laurin N., Lee J., Ickowicz A., Pathare T., Malone M., Tannock R. et al. 2008 Association study for genes at chromosome 5p13-q11 in attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 600–605.
Lee K., Kunugi H. and Nanko S. 2001 Glial cell line-derived neurotrophic factor (GDNF) gene and schizophrenia: polymorphism screening and association analysis. Psychiatry Res. 104(1), 11–17.
Li M. D., Cheng R., Ma J. Z. and Swan G. E. 2003 A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98(1), 23–31.
Lin L. F., Doherty D. H., Lile J. D., Bektesh S. and Collins F. 1993 GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130–1132.
Lyons M., Hitsman B., Xian H., Panizzon M. S., Jerskey B. A., Santangelo S. et al. 2008 A twin study of smoking, nicotine dependence, and major depression in men. Nicotine Tob. Res. 10, 97–108.
Madden P. A., Heath A. C., Pedersen N. L., Kaprio J., Koskenvuo M. J. and Martin N. G. 1999 The genetics of smoking persistence in men and women: a multicultural study. Behav. Genet. 29, 423–431.
Madden P. A., Pedersen N. L., Kaprio J., Koskenvuo M. J. and Martin N. G. 2004 The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. Twin Res. 7, 82–97.
Maes H. H., Sullivan P. F., Bulik C. M., Neale M. C., Prescott C. A., Eaves L. J. et al. 2004 A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol. Med. 34, 1251–1261.
Messer C. J., Eisch A. J., Carlezon J. W. A., Whisler K., Shen L., Wolf D. H. et al. 2000 Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26, 247–257.
Michelato A., Bonvicini C., Ventriglia M., Scassellati C., Randazzo R., Bignotti S. et al. 2004 3\(^{\prime }\) UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci. Lett. 357, 235–237.
Miller R. G. 1981 Simultaneous statistical inference, 2nd edition. Springer-Verlag, New York.
Muszbek K., Szekely A., Balogh E. M., Molnar M., Rohanszky M., Ruzsa A. et al. 2006 Validation of the Hungarian translation of Hospital Anxiety and Depression Scale. Qual. Life Res. 15, 761–766.
Nitta A., Nishioka H., Fukumitsu H., Furukawa Y., Sugiura H., Shen L. et al. 2004 Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis. J. Neurosci. Res. 78, 250–258.
Niwa M., Nitta A., Yamada Y., Nakajima A., Saito K., Seishima M. et al. 2007 An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization. Biol. Psychiatry 61, 890–901.
Pidoplichko V. I., DeBiasi M., Williams J. T. and Dani J. A. 1997 Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390, 401–404.
Pontieri F. E., Tanda G., Orzi F. and Di Chiara G. 1996 Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382, 255–257.
Sullivan P. F. and Kendler K. S. 1999 The genetic epidemiology of smoking. Nicotine Tob. Res. 1 suppl 2, S51–S57 (discussion S69–S70).
Syed Z., Dudbridge F. and Kent L. 2007 An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144, 375–378.
Thorgeirsson T. E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K. P. et al. 2008 A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638–642.
Tobacco and Genetics Consortium. 2010 Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441–447.
Urbán R., Kugler G. and Szilágyi Z. 2004 A nikotindependencia mérése és korrelátumai magyar felnőtt mintában. Addiktológia 3, 331–356.
Williams H. J., Norton N., Peirce T., Dwyer S., Williams N. M., Moskvina V. et al. 2007 Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia. Schizophr. Res. 97, 271–276.
Yan Y., Yamada K., Niwa M., Nagai T., Nitta A. and Nabeshima T. 2007 Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial-cell-line-derived neurotrophic factor mutant mice. FASEB J. 21, 1994–2004.
Yoshimura T., Usui H., Takahashi N., Yoshimi A., Saito S., Aleksic B. et al. 2011 Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1268–1272.
Zigmond A. S. and Snaith R. P. 1983 The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361–370.
Acknowledgements
This work was supported by the Hungarian Scientific Research Funds (OTKA K100845, K83766 and K111938) and we thank the Active Psychology Foundation and the postdoctoral scholarship awarded to Eszter Kotyuk by the Hungarian Academy of Sciences.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: S. Ganesh
[Kotyuk E., Nemeth N., Ronai Z., Demetrovics Z., Sasvari-Szekely M. and Szekely A. 2016 Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor. J. Genet. 95, xx–xx]
Rights and permissions
About this article
Cite this article
KOTYUK, E., NEMETH, N., RONAI, Z. et al. Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor. J Genet 95, 811–818 (2016). https://doi.org/10.1007/s12041-016-0701-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-016-0701-7